19 June 2021 - 12:00-20:00

1: Conventional needle EMG
Christian Krarup, Copenhagen, Denmark

2: Single fiber EMG
Sanjeev Nandedkar, New York, United States of America

1: 73 year old man with sudden onset of dysphagia, diplopia.VBI?
Laszlo Csiba, Debrecen, Hungary

2: 17 year old female with sudden aphasia during horse riding
Fabienne Perren, Lausanne, Switzerland

3: A young male patient with functional complains
Natan Bornstein, Tel-Aviv, Israel

1. Impact of COVID-19 on people with chronic neurological disease
Johann Sellner, Mistelbach, Austria

2. The patient´s perspective: analysis of the EFNA survey
Donna Walsh, Brussels, Belgium

3. Disruption of neurological patient care  
Marialuisa Zedde, Reggio Emilia, Italy

4. Neurological side effects of SARS-CoV-2 vaccination
Elena Moro, Grenoble, France

5. Impact of COVID-19 pandemic on neurology residents and research fellows in Europe
Giovanni Di Liberto, Lausanne, Switzerland

1: C. David Marsden Award Lecture: Cognition and Movement 
TBA

2: Video Cases
TBA

3: Dystonia Europe
David Marsden Award Winner                 

1: Epidemiology is different but the course of the disease is similar
Maged Abdel Naseer, Cairo, Egypt

2: Diagnosis and diagnostics: from direct and indirect CNS and PNS affection to molecular diagnostics
Renaud Du Pasquier, Lausanne, Switzerland

3: Managing the Covid pandemic in sub-Saharan Africa: The South Africa experience
Lawrence Tucker, Cape Town, South Africa

1: Genotype-phenotype relationship in neuromuscular diseases (challenges and opportunities)
Volker Straub, Newcastle, United Kingdom

2: Novel molecular strategies to solve ultra-rare diseases (The Solve-RD Project)
Holm Graessner, Tubingen, Germany

3: Personalized Treatments in rare neurologic diseases
Hugh Kearney, Dublin, Ireland

4: Clinical and Imaging biomarkers in X-linked adrenoleukodystrophy
Marc Engelen, Amsterdam, The Netherlands

1. Migraine prevention targeting CGRP. New evidence on efficacy and safety
Zaza Katsarava, Essen, Germany

2. A comparison of monoclonal antibodies targeting the CGRP pathway 
Dimos Mitsikostas, Athens, Greece

3. Individualizing preventive treatment in clinical practice: combination therapy and switching between CGRP antibodies
Pablo Irimia, Pamplona, Spain
 

1: Sleep/wake Mechanisms of the brain & Why Do We Sleep?
Rolf Fronczek, Leiden, The Netherlands

2: Diagnostics & Methods – Sleep Investigations and Pitfalls
Stefan Seidel, Vienna, Austria

3: Neurological Primary Sleep Disorders – Symptoms, Diagnosis & Treatment
Stine Knudsen-Heier, Oslo, Norway

4: Sleep pathology in Neurological Disorders
Fabio Pizza, Bologna, Italy

1: The Diagnostic challenge of Psychogenic Non Epileptic Seizures (PNES): red flags and common pitfalls
Markus Reuber, Sheffield, United Kingdom

2: Behind the PNES curtain: understanding pathogenic mechanisms
Selma Aybek Rusca, Bern, Switzerland

3: Neurophysiology and neuroimaging contribution to PNES diagnosis and understanding
Angelo Labate, Catanzaro, Italy

4: Therapeutic approach to PNES: from diagnosis communication to long-term management
Coraline Hingray, Nancy, France

1: Basics of neuroimmunology
Roland Liblau, Toulouse, France

2: What the Neurologist needs to know in choosing the right assay for autoantibody Testing
Romana Höftberger, Vienna, Austria

3: Demyelinating and Autoimmune Myelopathies
Maria Isabel da Silva Leite, Oxford, United Kingdom

4: Autoimmune encephalitis
Maarten Titulaer, Rotterdam, Netherlands

1: Clinical approach to the patient with vertigo and dizziness
Alexandre Bisdorff, Luxembourg

2: Peripheral vestibular disorders
Michael Strupp, Munich, Germany

3: Central and functional vestibular disorders
Marianne Dieterich, Munich, Germany

4: Central and peripheral ocular motor disorders, including nystagmus
Caroline Froment, Lyon, France

TBA

1: Why the gut-brain axis is important for precision neurology – the neuroscientist’s view
Sarah Vascellari, Cagliari, Italy

2: The gut-brain axis in multiple sclerosis and neuroinflammation: pathophysiology and targets for therapy
Hartmut Wekerle, Munich, Germany

3: Does gut microbiota play a role in neurodegenerative disorders?
Filip Scheperjans, Helsinki, Finland

4: Is there a role for the gut-brain axis in the pathophysiology and treatment of epilepsy?
Katrien De Looze, Ghent, Belgium